Amoy Diagnostics>   Hua Dong
Hua Dong

Hua Dong

Hua Dong is a highly skilled professional with 12.3 years of experience in bioinformatics, genomics, genetics, and drug discovery. Based in Shanghai, China, he has worked in various roles in the life sciences and biotechnology industry, including as a Director at Amoy Diagnostics and 3DMedcare. Hua has also held positions at 3dmedicines and Xinhua Pharmaceuticals, where he contributed to the development of innovative medical devices and medical devices. With a strong background in molecular biology and molecular biology, Hua is well-equipped to contribute to the field of NGS products R&D. .Read More

Hua Dong Contact information

Add to List
Sequence
Dialer

Hua Dong Current Workspace

Angela Work Summary

Number of Companies worked For
7
Average duration at company ( Year )
2
Number of job Positions
6

About Hua Dong

NGS Products R&D .Read More

Hua Dong’s Activities

📅Save the Date!📅 Webinar: AmoyDx® HRD Focus - Enabling Local NGS Diagnostics for Ovarian Cancer Patients Date: June 23, 2021 13:00-14:20 GMT Time… .Read More
Show all activites

Hua Dong's Current Workspace

Amoy Diagnostics
Amoy Diagnostics2020-01-01 - Present
Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and ADx-HANDLE® technologies, AmoyDx has a market-leading portfolio of molecular diagnostic assays. Based on multiple technology platforms including PCR, NGS, FISH and IHC, AmoyDx's core product categories include but not limit to single gene testing kits, multi-gene testing panels, NGS panels and NGS analytical systems. In the past years, more than 20 diagnostic kits have been approved by the Chinese authorities, the NMPA and in Europe (CE mark). In several External Quality Assessment (EQA) programs, including EMQN and PQCC, AmoyDx is the NO. 1 testing kit supplier for years and always achieves the highest accuracy rates. Nowadays, AmoyDx serves an extensive domestic and international oncology network, reaching over 500 top hospitals in China and over 50 countries worldwide. Every year hundreds of thousands of cancer patients benefit from AmoyDx products and services. As diagnostic partner with AstraZeneca, Johnson & Johnson, Amgen, Eli Lilly, Merck, Eisai, Hengrui and BeiGene, AmoyDx provides diagnostic products and services for trials of drugs in clinical development and for clinical practice. AmoyDx® ROS1 kit was the first approved companion diagnostic kit for Pfizer's crizotinib by Japanese and South Korean authorities. Our mission is to improve healthcare and patients' lives with superior & innovative products and services. Our vision is to be one of the global leading and most reliable suppliers of quality diagnostic products and services for personalized healthcare. .Read More

Hua Dong's Work Experiance

  • ldt director at amoydx2020-01-01 - Present
    Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and ADx-HANDLE® technologies, AmoyDx has a market-leading portfolio of molecular diagnostic assays. Based on multiple technology platforms including PCR, NGS, FISH and IHC, AmoyDx's core product categories include but not limit to single gene testing kits, multi-gene testing panels, NGS panels and NGS analytical systems. In the past years, more than 20 diagnostic kits have been approved by the Chinese authorities, the NMPA and in Europe (CE mark). In several External Quality Assessment (EQA) programs, including EMQN and PQCC, AmoyDx is the NO. 1 testing kit supplier for years and always achieves the highest accuracy rates. Nowadays, AmoyDx serves an extensive domestic and international oncology network, reaching over 500 top hospitals in China and over 50 countries worldwide. Every year hundreds of thousands of cancer patients benefit from AmoyDx products and services. As diagnostic partner with AstraZeneca, Johnson & Johnson, Amgen, Eli Lilly, Merck, Eisai, Hengrui and BeiGene, AmoyDx provides diagnostic products and services for trials of drugs in clinical development and for clinical practice. AmoyDx® ROS1 kit was the first approved companion diagnostic kit for Pfizer's crizotinib by Japanese and South Korean authorities. Our mission is to improve healthcare and patients' lives with superior & innovative products and services. Our vision is to be one of the global leading and most reliable suppliers of quality diagnostic products and services for personalized healthcare. .Read More

    Location

    厦门市, 福建省, 361027, CN

    Industry